There are six tumor necrosis factor inhibitors available now, all by prescription only:
- Adalimumab (Humira)
- Adalimumab-atto (Amjevita), a biosimilar to Humira
- Certolizumab pegol (Cimzia)
- Etanercept (Enbrel)
- Etanercept-szzs (Ereizi), a biosimilar to Enbrel
- Golimumab (Simponi, Simponi Aria)
- Infliximab (Remicade)
- Infliximab-dyyb (Inflectra), a biosimilar to Remicade